System Access Manager
- Secure user administration module
- Manages unique electronic signatures
- Full and detailed audit trails
- Highly configurable user account rules
- Enforces password changes and rules on password re-use
- Login timeouts and lockouts to prevent unauthorized access
Manage users in a compliant environment
System Access Manager strengthens compliance by managing and maintaining user access. The System Access Manager solution is required for use with Ames Study Manager & Cyto Study Manager, and can be used alongside Comet Assay IV & Sorcerer Colony Counter to achieve a fully compliant arrangement.
System Access Manager supports compliance for organizations that adhere to Good Laboratory Practice (GLP) or Good Manufacturing Practice (GMP) regulations, or for companies who comply with the FDA 21 CFR Part 11 Final rule on Electronic Records and Electronic Signatures.
Password rules and electronic signatures
Individual users are assigned unique user IDs and access rights to each product. The program manages user access via a wide range of password rules including expiry, length, use of characters & numbers, etc. User Administrators can add new users to the database and assign them a unique User ID, a User Name and duration of password validity, as well as defining a specific access level and time-out to each product.
Comprehensive audit trails
System Access Manager provides comprehensive security and full audit trails that record all login attempts and changes to a user’s account validity or access permissions. The audit trails can be filtered on any field, such as User ID, event description or date. Audit trails can be exported to Excel for printing or review. System Access Manager is built around a secure Oracle database, providing complete security of user and audit data.
You work to GLP and so do our genetox solutions…
All of Instem’s genetox solutions are designed with reference to the OECD and S2(R1) guidelines. We ensure our solutions are fully compliant with the principles of Good Laboratory Practice (GLP) and the FDA 21 CFR part 11 rule on electronic signatures.